All products / DC20049
Y06036
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $1,500 USDRequest a quote / confirm availability → |
| 250 mg | $3,000 USDRequest a quote / confirm availability → |
| 1 g | $6,000 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
In Vitro Y06036 (0.001-100 nM, 96 hours for LNCaP, C4-2B, and 22Rv1 cells; 144 hours for VCaP cells) exhibits low micromolar or nanomolar potencies (IC50: 0.29-2.6 μΜ) in the four androgen receptor (AR)-positive prostate cancer cell lines LNCaP, C4-2B, 22Rv1, and VCaP. Treatment of 22Rv1 cells with Y06036 (1, 2, 4, 8, and 16 μM, 48 hours) results in significant down-regulation of both full-length (AR-fl) and AR variants levels. In Vivo Y06036 (50 mg/kg, i.p. injection, 5 times per week, 25 days) demonstrates therapeutic effects in a C4-2B CRPC xenograft tumor model in mice. Y06036 is well tolerated in the treated mice, based on the weight of the animal body and their general behavior.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC20049 |
|---|---|
| Product name | Y06036 |
| CAS | 1832671-96-1 |
| Molecular formula | C16H15BrN2O5S |
| Molecular weight | 427.27 |
| Purity | >98% |
| SMILES | COc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Y06036 (DC20049)